118 related articles for article (PubMed ID: 9208532)
1. [A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy].
Li JH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Mar; 16(3):136-8. PubMed ID: 9208532
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effect of Chinese medicinal herbs combined with chemotherapy on advanced non-small cell lung cancer].
Huang ZM; Long H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Jan; 17(1):26-8. PubMed ID: 9812647
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
Takifuji N; Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Masuda N; Ryu S; Sakai N; Kubota K
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):429-34. PubMed ID: 2157364
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
Segawa Y; Kiura K; Takigawa N; Kamei H; Harita S; Hiraki S; Watanabe Y; Sugimoto K; Shibayama T; Yonei T; Ueoka H; Takemoto M; Kanazawa S; Takata I; Nogami N; Hotta K; Hiraki A; Tabata M; Matsuo K; Tanimoto M
J Clin Oncol; 2010 Jul; 28(20):3299-306. PubMed ID: 20530281
[TBL] [Abstract][Full Text] [Related]
5. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Yamazaki S; Sekine I; Matsuno Y; Takei H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Asamura H; Tsuchiya R; Saijo N
Lung Cancer; 2005 Aug; 49(2):217-23. PubMed ID: 16022916
[TBL] [Abstract][Full Text] [Related]
6. [Effect of combination of syndrome differentiation depending treatment and chemotherapy on prognostic factors in treating mid-late patients with non-small call lung cancer].
Li LN; Liu WS; Xu K
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):575-9. PubMed ID: 14503053
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
8. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Fujii M; Kiura K; Okabe K; Toki H; Kimura M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
[TBL] [Abstract][Full Text] [Related]
9. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
Zhang X; Sun Y; Feng F
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on treatment of advanced stage non-small cell lung cancer by guben xiaoliu capsule].
Wang XM; Xin H; Yang Z; Zhao W; Yang G; Liu J; Tang W; Zhang Q; Han D; Yu R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Nov; 24(11):986-8. PubMed ID: 15609595
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
12. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
[TBL] [Abstract][Full Text] [Related]
13. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
[TBL] [Abstract][Full Text] [Related]
15. [Effect of traditional Chinese medicine in improving quality of life of patients with non-small cell lung cancer in late stage].
Lin LZ; Zhou DH; Zheng XT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 May; 26(5):389-93. PubMed ID: 16883901
[TBL] [Abstract][Full Text] [Related]
16. [Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].
Zhou CC; Zhang J; Zheng D; Lu MJ; Lu B; Xu JF
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):546-8. PubMed ID: 15388005
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of chemotherapy of unresectable non-small cell lung cancer].
Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kawakami K; Mishima M; Kuno K
Gan To Kagaku Ryoho; 1992 Jan; 19(1):55-60. PubMed ID: 1309632
[TBL] [Abstract][Full Text] [Related]
18. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.
Turrisi AT; Kim K; Blum R; Sause WT; Livingston RB; Komaki R; Wagner H; Aisner S; Johnson DH
N Engl J Med; 1999 Jan; 340(4):265-71. PubMed ID: 9920950
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life].
Rolski J; Zemełka T; Jasiówka M; Czyzewicz G; Kojs-Pasińska E
Pneumonol Alergol Pol; 2007; 75(4):343-8. PubMed ID: 18080983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]